Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITE DE CAEN NORMANDIE is navigating the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This indicates a targeted effort to secure its technical developments. The institution is currently focused on resolving this single outstanding matter to advance its application through the patent office.
The prosecution of this portfolio is handled by 1 distinct examiner and 1 distinct art unit. This centralized structure shows that the technology is being evaluated within a specific technical silo. For the practitioner, this lack of diversity in examiners and art units simplifies the prosecution landscape, as there is only one set of departmental standards to navigate.
BAEK, JONGHWAN NMN is the busiest examiner assigned to this portfolio. This individual is currently managing the 1 busiest examiner pending office action. Because BAEK, JONGHWAN NMN is responsible for the entire pending workload, the success of the current prosecution cycle depends entirely on this examiner. A deep understanding of the specific preferences of BAEK, JONGHWAN NMN is essential for resolving the 1 pending office action efficiently.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, JONGHWAN NMN | 1 | 60.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18274571 | AZA-CRYPTOPHANES, PROCESSES FOR PREPARATION THEREOF, AND THEIR USES | BAEK, JONGHWAN NMN | 1618 | §103 | Final Rejection | 26d | Pending | Jul 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial